Clinical Trial Update: Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1) [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing immune response and general immune health in subjects infected with HSV-1 has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis
• Herpes Simplex Virus Infection

Snippet

Sponsor: Squarex, LLC | Conditions: HSV, Herpes Labialis | Phase 1 | Status: COMPLETED | Results posted: 2021-11-03